Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is ...

The Food and Drug Administration on Thursday delivered a split decision to a blood cancer drug from GSK, approving its use in ...

WASHINGTON — The Trump administration’s push to make in vitro fertilization more affordable is changing the outlook and ...

Can Trump take credit for North Carolina's booming biopharma industry? Which drugs could get a shortcut to the market? All ...

New analysis finds the median net price for 154 newly launched drugs, when adjusted for inflation and manufacturer discounts, ...

In today's D.C. Diagnosis newsletter, Florida Gov. Ron DeSantis downplays the importance of health insurance as the shutdown ...

Moderna's experimental vaccine for cytomegalovirus, a cause of disability in newborns, failed in a Phase 3 trial ...

This week’s XBI pullback is healthy. Biotech stocks cannot go up every day. The sector’s recovery off the April lows has been ...

Living with a neurologic illness is an exercise in ambiguity,” Shaheen Lakhan writes in a powerful essay about the blurry ...

Moderna’s highly touted cytomegalovirus vaccine — long billed as its next big win after its Covid-19 shot — failed a Phase 3 ...

CVS Caremark, the largest PBM in the U.S., tells activists Gilead needs to lower the price of its new HIV drug to get on ...

“I thought having the vaccines would protect our children,” said Erik Dahlberg, the boy’s father. “Unfortunately, it did not ...